Date: April 22, 2014
Buyer: Eli Lilly
Seller: Novartis Animal Health
Price: $5.4 Billion
Terms: Acquisition
On April 22nd Novartis Animal Health was sold to Eli Lilly. Eli Lilly purchased Novartis Animal Health for a whopping $5.4B in cash, which is the second-largest deal in the company’s history. The acquisition will diversify Lilly’s existing animal health business by folding the $1.1-billion-in-revenue Novartis Animal Health into its Greenfield-based Elanco division, making it the world’s second-largest animal health company by revenue. Novartis will greatly expand and complement Elanco’s product portfolio, R&D and manufacturing capabilities, and commercial presence in key geographies.
“Animal health continues to represent an attractive growth opportunity for Lilly. We intend to keep Elanco and to take advantage of the substantial synergies between our animal health and human health businesses,” Eli Lilly CEO John Lechleiter said in a prepared statement.